These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 9753220
21. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor. Udagawa A, Shiota G, Ichiba M, Murawaki Y. Scand J Gastroenterol; 2003 Feb; 38(2):141-6. PubMed ID: 12678329 [Abstract] [Full Text] [Related]
25. Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa. Suetsugu H, Ishihara S, Moriyama N, Kazumori H, Adachi K, Fukuda R, Watanabe M, Kinoshita Y. J Lab Clin Med; 2000 Jul 25; 136(1):50-7. PubMed ID: 10882227 [Abstract] [Full Text] [Related]
26. The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide. Choi HS, Lim JY, Chun HJ, Lee M, Kim ES, Keum B, Seo YS, Jeen YT, Um SH, Lee HS, Kim CD, Ryu HS, Sul D. Life Sci; 2013 Jul 30; 93(2-3):69-77. PubMed ID: 23743168 [Abstract] [Full Text] [Related]
27. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells. Masamune A, Yoshida M, Sakai Y, Shimosegawa T. J Pharmacol Exp Ther; 2001 Aug 30; 298(2):485-92. PubMed ID: 11454909 [Abstract] [Full Text] [Related]
28. Protective effect of rebamipide against ammonia-induced gastric mucosal lesions. Takaishi O, Arakawa T, Yamasaki K, Fujiwara Y, Uchida T, Tominaga K, Watanabe T, Higuchi K, Fukuda T, Kobayashi K, Kuroki T. Dig Dis Sci; 1998 Sep 30; 43(9 Suppl):78S-82S. PubMed ID: 9753231 [Abstract] [Full Text] [Related]
29. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils. Han BG, Kim HS, Rhee KH, Han HS, Chung MH. Pharmacol Res; 1995 Oct 30; 32(4):201-7. PubMed ID: 8866835 [Abstract] [Full Text] [Related]
30. Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells. Murata H, Yabe Y, Tsuji S, Tsujii M, Fu HY, Asahi K, Eguchi H, Kawano S, Hayashi N. Dig Dis Sci; 2005 Oct 30; 50 Suppl 1():S70-5. PubMed ID: 16184424 [Abstract] [Full Text] [Related]
31. Rebamipide solution: a novel submucosal injection material to promote healing speed and healing quality of ulcers induced by endoscopic submucosal dissection. Fujimoto A, Uraoka T, Nishizawa T, Shimoda M, Goto O, Ochiai Y, Maehata T, Akimoto T, Mitsunaga Y, Sasaki M, Yamamoto H, Yahagi N. Gastrointest Endosc; 2018 Apr 30; 87(4):1114-1120. PubMed ID: 28993136 [Abstract] [Full Text] [Related]
36. Gastric cytoprotection beyond prostaglandins: cellular and molecular mechanisms of gastroprotective and ulcer healing actions of antacids. Tarnawski A, Ahluwalia A, Jones MK. Curr Pharm Des; 2013 Apr 30; 19(1):126-32. PubMed ID: 22950493 [Abstract] [Full Text] [Related]
37. Rebamipide: a gastrointestinal protective drug with pleiotropic activities. Naito Y, Yoshikawa T. Expert Rev Gastroenterol Hepatol; 2010 Jun 30; 4(3):261-70. PubMed ID: 20528113 [Abstract] [Full Text] [Related]
38. Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat. Kim CD, Hong KW. J Pharmacol Exp Ther; 1995 Oct 30; 275(1):340-4. PubMed ID: 7562569 [Abstract] [Full Text] [Related]
40. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. Aihara M, Azuma A, Takizawa H, Tsuchimoto D, Funakoshi Y, Shindo Y, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K. Dig Dis Sci; 1998 Sep 30; 43(9 Suppl):174S-180S. PubMed ID: 9753246 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]